Massachusetts Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
1,072,331
+149,830
+16% +$2.39M 0.01% 689
2025
Q4
$15M Sell
922,501
-317,124
-26% -$5.18M ﹤0.01% 679
2025
Q3
$18.5M Sell
1,239,625
-222,486
-15% -$2.71M 0.01% 641
2025
Q2
$17M Sell
1,462,111
-844,201
-37% -$7.67M 0.01% 635
2025
Q1
$17.1M Sell
2,306,312
-1,064,607
-32% -$8.18M 0.01% 612
2024
Q4
$20.2M Buy
3,370,919
+489,555
+17% +$2.7M 0.01% 599
2024
Q3
$14.8M Sell
2,881,364
-1,030,663
-26% -$4.49M ﹤0.01% 623
2024
Q2
$14.2M Buy
3,912,027
+1,319,709
+51% +$4.19M ﹤0.01% 611
2024
Q1
$8.32M Sell
2,592,318
-11,182
-0.4% -$43.3K ﹤0.01% 636
2023
Q4
$12.8M Buy
2,603,500
+632,040
+32% +$2.88M ﹤0.01% 608
2023
Q3
$10.7M Sell
1,971,460
-148,149
-7% -$980K ﹤0.01% 615
2023
Q2
$14.2M Sell
2,119,609
-159,601
-7% -$1.19M ﹤0.01% 585
2023
Q1
$20.1M Buy
2,279,210
+924,777
+68% +$8.15M 0.01% 555
2022
Q4
$10.3M Buy
1,354,433
+140,518
+12% +$1.09M ﹤0.01% 609
2022
Q3
$8.64M Buy
1,213,915
+370,839
+44% +$3.49M ﹤0.01% 621
2022
Q2
$6.82M Sell
843,076
-2,034,767
-71% -$17.9M ﹤0.01% 631
2022
Q1
$39.9M Buy
2,877,843
+449,383
+19% +$7.07M 0.01% 512
2021
Q4
$68.1M Buy
2,428,460
+209,731
+9% +$6.43M 0.02% 453
2021
Q3
$75.4M Buy
2,218,729
+70,410
+3% +$2.55M 0.02% 431
2021
Q2
$87.8M Sell
2,148,319
-105,629
-5% -$4.11M 0.03% 418
2021
Q1
$90.7M Sell
2,253,948
-641,296
-22% -$34.7M 0.03% 394
2020
Q4
$171M Sell
2,895,244
-57,060
-2% -$2.94M 0.06% 264
2020
Q3
$144M Buy
2,952,304
+713,320
+32% +$30M 0.05% 265
2020
Q2
$108M Buy
2,238,984
+750,327
+50% +$27.4M 0.04% 306
2020
Q1
$41.4M Buy
1,488,657
+416,712
+39% +$11.6M 0.02% 401
2019
Q4
$32.1M Buy
1,071,945
+535,571
+100% +$15.4M 0.01% 473
2019
Q3
$16.6M Sell
536,374
-88,626
-14% -$3.62M 0.01% 553
2019
Q2
$30.2M Buy
+625,000
New +$27.7M 0.01% 470

Other funds holding ADPT